Urologix, Inc. (NASDAQ:ULGX), a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy treatment catheters that provide a durable and effective procedure delivered in the comfort of an urologist’s office for patients suffering from benign prostatic hyperplasia (BPH), reported financial results for the fiscal 2010 second quarter ended December 31, 2009. Related [...]

Continue reading " Urologix Reports Continued Revenue Growth in Second Quarter of Fiscal Year 2010 over Prior Periods "

* Increased Revenue by 4% Compared to Third Quarter Fiscal 2009 * Reduced Net Loss by 27% Compared to Third Quarter Fiscal 2009 * Reduced Operating Expenses by 5% Compared to Third Quarter Fiscal 2009 Urologix, Inc. (NASDAQ:ULGX), a medical device company focused on developing, manufacturing and marketing Cooled ThermoTherapy systems, a durable and effective [...]

Continue reading " Urologix Reports Fiscal 2009 Results Including Sequential Growth in Fourth Quarter Fiscal Year 2009 Revenue "

Urologix, Inc. (Nasdaq:ULGX) will host a conference call to present fiscal year 2009 and fourth quarter results on Tuesday, August 25, 2009 at 4:00 p.m. CT, following the Company’s post-market press release on the same day. Related posts Peter Rost of Pfizer and Eshetu Wondemagegnehu of the World Health Organization Speak Out About Drug Re-Importation [...]

Continue reading " Urologix to Host Its Fiscal Year 2009 and Fourth Quarter Conference Call "